Специалисты РНПЦ ОМР им.Н.Н.Александрова приняли участие в конгрессе Европейского общества гинекологической онкологии в Стамбуле

С 28 сентября по 1 октября 2023 г. в Стамбуле, Турция прошёл 24-й Европейский конгресс ESGO по гинекологической онкологии, который в этом году отмечает своё 40-летие.

Более 2400 участников из 100 стран собрались во время ESGO 2023, чтобы поучиться у более чем 100 ведущих мировых спикеров, которые выступили с докладами в более чем 50 секциях программы, а также просмотреть сотни электронных постеров.

На мероприятии учреждение представляли:

• Матылевич Ольга Павловна, заведующий лабораторией онкогинекологии
• Трухан Анна Владимировна, ведущий научный сотрудник лаборатории онкогинекологии
• Тарасов Илья Александрович, врач-онколог онкологического (гинекологического) отделения.

Ольга Павловна Матылевич (являющаяся консулом Европейского общества гинекологической онкологии ESGO) председательствовала в секции  «Tumour board 3: What is the Best Treatment Approach Beylerbeyi for Recurrent Cervical Cancer?» и представила доклад  «Pelvic Exenteration in Patients with Persistent and Recurrent Cervical Cancer: An Experience at National Cancer Centre of Belarus».

РНПЦ ОМР им. Н.Н. Александрова приняло участие в конгрессе ESGO c постерными докладами:

1. OVARIAN TUMORS DURING PREGNANCY: SINGLE CANCER CENTRE EXPERIENCE 1 Olga P Matylevich*, 1 Ilya A Tarasau, 2 Sviatlana Y Shelkovich, 1 Iryna Y Bakinouskaya, 3 Aliaksandr F Martsinkevich. 1 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 2 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 3 Vitebsk State Medical University, Vitebsk, Belarus 10.1136/ijgc-2023-ESGO.418 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
2. PULMONARY BENIGN METASTASIZING LEIOMYOMA Olga P Matylevich, Ilya A Tarasau*, Mikalay A Kurchankou, Pavel A Kopschaj, Alena V Dalamanava. NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus 10.1136/ijgc-2023-ESGO.459 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
3. RESULTS OF HORMONE THERAPY FOR ENDOMETRIAL CANCER STAGE 1A IN WOMEN OF REPRODUCTIVE AGE 1 Olga P Matylevich*, 1 Alena G Milishkevich, 2 Sviatlana Y Shelkovich. 1 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 2 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus 10.1136/ijgc-2023-ESGO.296 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
4. EFFECTIVENESS OF PHOTODYNAMIC THERAPY WITH PHOTOSENSITIZER PHOTOLON IN 150 WOMEN WITH CERVICAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION Olga P Matylevich*, Tatsiana P Artsemyeva, Dmitry A Tzerkovsky, Oksana A Erochina. NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus 10.1136/ijgc-2023-ESGO.720 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
5. REPRODUCTIVE OUTCOMES AFTER FERTILITY-SPARING SURGERY FOR CERVICAL CANCER – RESULTS OF THE FERTISS STUDY 1 Jiri Slama*, 2 Ingo Runnebaum, 3 Giovanni Scambia, 4 Martina Angeles Fite, 5 Kiarash Bahrehmand, 6 Stefan Kommoss, 7 Fabrice Narducci, 8 Olga Matylevich, 9 Jessica Holly, 10Fabio Martinelli, 11Meriem Koual, 12Olena Samokhvalova, 13Ahmed ElBalat, 3 Giacomo Corrado, 14Mihai Emil Capîlna, 15Willibald Schröder, 5 Zoltán Novàk, 8 Alexander Shushkevich, 16Lenka Fricova, 16David Cibula. 1 Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, CEEGOG, Prague, Czech Republic; 2 Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University, AGO Study Group, Jena, Germany; 3 Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart Rome, MITO, Rome, Italy; 4 Claudius Regaud Institute – University Cancer Institute, GINECO, Toulouse, France; 5 Department of Gynecology, Hungarian National Institute of Oncology, CEEGOG, Budapest, Hungary; 6 Tuebingen University Hospital, Department of Women’s Health, AGO Study Group, Tuebingen, Germany; 7 Department of Gynecology Oncology, Oscar Lambret Cancer Center, GINECO, Lille, France; 8 Gynecologic Oncology Department, N.N. Alexandrov National Cancer Centre of Belarus, CEEGOG, Minsk, Belarus; 9 Department of Gynecological Oncology, Evangelical Clinic Essen Mitte, Germany, AGO Study Group, Essen, Germany; 10Fondazione IRCCS Istituto Nazionale Tumori – Milan, MITO, Milan, Italy; 11Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, GINECO, Paris, France; 12Department of Gynecologic Oncology, National Cancer Institute, CEEGOG, Kyiv, Ukraine; 13University Clinic Frankfurt, Goethe-University, Department of Gynecology and Obstetrics, Frankfurt am Main, Germany; Spital Uster, Women’s Hospital, AGO Study Group, Uster, Switzerland; 14First Obstetrics and Gynecology Clinic,, Târgu Mure?, Romania; 15Gynaekologicum Bremen, AGO Study Group, Bremen, Germany; 16Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic, CEEGOG, Prague, Czech Republic 10.1136/ijgc-2023-ESGO.21 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
6. RESULTS OF HORMONE THERAPY FOR ENDOMETRIAL CANCER STAGE 1A IN WOMEN OF REPRODUCTIVE AGE 1 Olga P Matylevich*, 1 Alena G Milishkevich, 2 Sviatlana Y Shelkovich. 1 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 2 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus 10.1136/ijgc-2023-ESGO.296 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
7. SURVIVAL OF PATIENTS WITH BRAIN METASTASES FROM OVARIAN CANCER: RETROSPECTIVE MONOCENTRIC STUDY 1 Hanna Trukhan*, 2 Valeria Skachkova, 3 Volha Ramanovich, 3 Sergey Mavrichev, 3 Alena Dalamanavs, 4 Darya Brashko. 1 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 2 National Molecular Genetics Laboratory of Cancer Research, Minsk, Belarus; 3 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 4 Minimally Invasive Surgery Department, Minsk City Clinical Cancer Center, Minsk, Belarus 10.1136/ijgc-2023-ESGO.605 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
8. PATIENTS WITH BRAIN METASTASES FROM OVARIAN CANCER 1 Hanna Trukhan*, 2 Valeria Skachkova, 3 Volha Ramanovich, 3 Sergey Mavrichev, 3 Alena Dalamanava. 1 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 2 National Molecular Genetics Laboratory of Cancer Research, Minsk, Belarus; 3 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus 10.1136/ijgc-2023-ESGO.606 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
9. TREATMENT OPTIONS FOR PATIENTS WITH BRAIN METASTASES FROM OVARIAN CANCER: RETROSPECTIVE MONOCENTRIC STUDY 1 Hanna Trukhan*, 2 Valeria Skachkova, 2 Yuliya Luferova, 3 Sergey Mavrichev, 3 Alena Dalamanava, 3 Yulia Petrushenka, 4 Olga Morozova. 1 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 2 National Molecular Genetics Laboratory of Cancer Research, Minsk, Belarus; 3 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 4 Polotsk Central City Hospital, Minsk, Belarus 10.1136/ijgc-2023-ESGO.604 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453

Тарасов Илья Александрович принял участие в 6-м информационном забеге ESGO совмещенном с "Прогулкой во имя здоровья", направленном на повышение осведомленности о раннем выявлении гинекологического рака и программах вакцинации против ВПЧ. Пробежать 5 км или пройти 2 км по парку Мачка, чтобы пропагандировать здоровый образ жизни, который напрямую влияет на заболеваемость гинекологическим раком.

Ольге Павловне Матылевич вручили сертификат профессионального признания в Европе, который был признан соответствующим Европейским обществом гинекологической онкологии (ESGO). Этот документ указывает на то, что мы зарегистрированы в Европе в области гинекологической онкологии.

 

Specialists of the N.N. Alexandrov National Cancer Center of Belarus took part in the congress of the European Society of Gynecological Oncology in Istanbul

From September, 28 to October, 1st of 2023, the 24th ESGO European Congress of Gynecological Oncology was held in Istanbul, Turkey, which celebrates its 40th anniversary this year.

More than 2,400 participants from 100 countries gathered during ESGO 2023 to learn from more than 100 of the world's leading speakers who delivered presentations in more than 50 sections of the program, as well as view hundreds of e-posters.

The institution was represented at the event by:

• Olga Pavlovna Matylevich, head of the laboratory of gynecological oncology
• Trukhan Anna Vladimirovna, leading researcher at the laboratory of gynecological oncology
• Tarasov Ilya Aleksandrovich, oncologist of the oncology (gynecological) department

Olga Pavlovna Matylevich (who is the Consul of the European Society of Gynecological Oncology ESGO) chaired the section «Tumour board 3: What is the Best Treatment Approach Beylerbeyi for Recurrent Cervical Cancer?» and presented a report «Pelvic Exenteration in Patients with Persistent and Recurrent Cervical Cancer: An Experience at National Cancer Centre of Belarus».

N.N. Alexandrov National Cancer Center of Belarus took part in the ESGO Congress with poster presentations:

1. OVARIAN TUMORS DURING PREGNANCY: SINGLE CANCER CENTRE EXPERIENCE 1 Olga P Matylevich*, 1 Ilya A Tarasau, 2 Sviatlana Y Shelkovich, 1 Iryna Y Bakinouskaya, 3 Aliaksandr F Martsinkevich. 1 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 2 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 3 Vitebsk State Medical University, Vitebsk, Belarus 10.1136/ijgc-2023-ESGO.418 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
2. PULMONARY BENIGN METASTASIZING LEIOMYOMA Olga P Matylevich, Ilya A Tarasau*, Mikalay A Kurchankou, Pavel A Kopschaj, Alena V Dalamanava. NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus 10.1136/ijgc-2023-ESGO.459 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
3. RESULTS OF HORMONE THERAPY FOR ENDOMETRIAL CANCER STAGE 1A IN WOMEN OF REPRODUCTIVE AGE 1 Olga P Matylevich*, 1 Alena G Milishkevich, 2 Sviatlana Y Shelkovich. 1 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 2 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus 10.1136/ijgc-2023-ESGO.296 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
4. EFFECTIVENESS OF PHOTODYNAMIC THERAPY WITH PHOTOSENSITIZER PHOTOLON IN 150 WOMEN WITH CERVICAL HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION Olga P Matylevich*, Tatsiana P Artsemyeva, Dmitry A Tzerkovsky, Oksana A Erochina. NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus 10.1136/ijgc-2023-ESGO.720 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
5. REPRODUCTIVE OUTCOMES AFTER FERTILITY-SPARING SURGERY FOR CERVICAL CANCER – RESULTS OF THE FERTISS STUDY 1 Jiri Slama*, 2 Ingo Runnebaum, 3 Giovanni Scambia, 4 Martina Angeles Fite, 5 Kiarash Bahrehmand, 6 Stefan Kommoss, 7 Fabrice Narducci, 8 Olga Matylevich, 9 Jessica Holly, 10Fabio Martinelli, 11Meriem Koual, 12Olena Samokhvalova, 13Ahmed ElBalat, 3 Giacomo Corrado, 14Mihai Emil Capîlna, 15Willibald Schröder, 5 Zoltán Novàk, 8 Alexander Shushkevich, 16Lenka Fricova, 16David Cibula. 1 Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, CEEGOG, Prague, Czech Republic; 2 Department of Gynecology and Reproductive Medicine, Jena University Hospital, Friedrich Schiller University, AGO Study Group, Jena, Germany; 3 Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart Rome, MITO, Rome, Italy; 4 Claudius Regaud Institute – University Cancer Institute, GINECO, Toulouse, France; 5 Department of Gynecology, Hungarian National Institute of Oncology, CEEGOG, Budapest, Hungary; 6 Tuebingen University Hospital, Department of Women’s Health, AGO Study Group, Tuebingen, Germany; 7 Department of Gynecology Oncology, Oscar Lambret Cancer Center, GINECO, Lille, France; 8 Gynecologic Oncology Department, N.N. Alexandrov National Cancer Centre of Belarus, CEEGOG, Minsk, Belarus; 9 Department of Gynecological Oncology, Evangelical Clinic Essen Mitte, Germany, AGO Study Group, Essen, Germany; 10Fondazione IRCCS Istituto Nazionale Tumori – Milan, MITO, Milan, Italy; 11Gynecologic and Breast Oncologic Surgery Department, Georges Pompidou European Hospital, GINECO, Paris, France; 12Department of Gynecologic Oncology, National Cancer Institute, CEEGOG, Kyiv, Ukraine; 13University Clinic Frankfurt, Goethe-University, Department of Gynecology and Obstetrics, Frankfurt am Main, Germany; Spital Uster, Women’s Hospital, AGO Study Group, Uster, Switzerland; 14First Obstetrics and Gynecology Clinic,, Târgu Mure?, Romania; 15Gynaekologicum Bremen, AGO Study Group, Bremen, Germany; 16Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic, CEEGOG, Prague, Czech Republic 10.1136/ijgc-2023-ESGO.21 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
6. RESULTS OF HORMONE THERAPY FOR ENDOMETRIAL CANCER STAGE 1A IN WOMEN OF REPRODUCTIVE AGE 1 Olga P Matylevich*, 1 Alena G Milishkevich, 2 Sviatlana Y Shelkovich. 1 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 2 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus 10.1136/ijgc-2023-ESGO.296 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
7. SURVIVAL OF PATIENTS WITH BRAIN METASTASES FROM OVARIAN CANCER: RETROSPECTIVE MONOCENTRIC STUDY 1 Hanna Trukhan*, 2 Valeria Skachkova, 3 Volha Ramanovich, 3 Sergey Mavrichev, 3 Alena Dalamanavs, 4 Darya Brashko. 1 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 2 National Molecular Genetics Laboratory of Cancer Research, Minsk, Belarus; 3 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 4 Minimally Invasive Surgery Department, Minsk City Clinical Cancer Center, Minsk, Belarus 10.1136/ijgc-2023-ESGO.605 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
8. PATIENTS WITH BRAIN METASTASES FROM OVARIAN CANCER 1 Hanna Trukhan*, 2 Valeria Skachkova, 3 Volha Ramanovich, 3 Sergey Mavrichev, 3 Alena Dalamanava. 1 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 2 National Molecular Genetics Laboratory of Cancer Research, Minsk, Belarus; 3 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus 10.1136/ijgc-2023-ESGO.606 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453
9. TREATMENT OPTIONS FOR PATIENTS WITH BRAIN METASTASES FROM OVARIAN CANCER: RETROSPECTIVE MONOCENTRIC STUDY 1 Hanna Trukhan*, 2 Valeria Skachkova, 2 Yuliya Luferova, 3 Sergey Mavrichev, 3 Alena Dalamanava, 3 Yulia Petrushenka, 4 Olga Morozova. 1 Belarusian Medical Academy of Postgraduate Education, Minsk, Belarus; 2 National Molecular Genetics Laboratory of Cancer Research, Minsk, Belarus; 3 NN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus; 4 Polotsk Central City Hospital, Minsk, Belarus 10.1136/ijgc-2023-ESGO.604 Int J Gynecol Cancer 2023;33(Suppl 3):A1–A453

Ilya Aleksandrovich Tarasov took part in the 6th ESGO information race combined with the “Walk for Health”, aimed at raising awareness about the early detection of gynecological cancer and HPV vaccination programs. Run 5 km or walk 2 km in Macka Park to promote a healthy lifestyle, which directly affects the incidence of gynecological cancer.

Olga Pavlovna Matylevich was awarded a certificate of professional recognition in Europe, which was recognized by the corresponding European Society of Gynecological Oncology (ESGO). This document indicates that we are registered in Europe in the field of gynecological oncology.